Efficacy of Denosumab for Osteoporosis in Two Patients with Adult-Onset Still’s Disease—Denosumab Efficacy in Osteoporotic Still’s Disease Patients

Efficacy of Denosumab for Osteoporosis in Two Patients with Adult-Onset Still’s Disease—Denosumab Efficacy in Osteoporotic Still’s Disease Patients

Adult-onset Still’s disease (AOSD) is an autoimmune inflammatory disorder. Glucocorticoids are often used for AOSD, which may induce complicating glucocorticoid-induced osteoporosis (GIO). An anti-resorption drug, denosumab, has recently been approved for osteoporosis treatment in Japan. However, th...

Full description

Bibliographic Details
Main Authors: Daiki Kumaki, Yukio Nakamura, Takako Suzuki, Hiroyuki Kato
Format: Article
Language:English
Published: MDPI AG 2018-03-01
Series:Journal of Clinical Medicine
Subjects:
adult-onset Still’s disease
bone mineral density
denosumab
osteoporosis
Online Access:http://www.mdpi.com/2077-0383/7/4/63

Internet

http://www.mdpi.com/2077-0383/7/4/63

Similar Items